Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study

被引：0
|
作者：
Mustafayev, Khalis [1 ]
Guevara, Eduardo Yepez [1 ]
DiNardo, Courtney D. [2 ]
Jabbour, Elias [2 ]
Ghayas, Issa C. [2 ]
Ratan, Ravin [3 ]
Pemmaraju, Naveen [2 ]
Torres, Harrys A. [1 ,4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
来源：
LEUKEMIA RESEARCH | 2024年 / 147卷
关键词：
Dasatinib; Imatinib; Ponatinib; Chronic myeloid leukemia; Viral hepatitis; HCV;
D O I：
10.1016/j.leukres.2024.107597
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
    Haddad, Fadi
    Kantarjian, Hagop
    Issa, Ghayas C.
    Jabbour, Elias
    Sasaki, Koji
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1714 - 1717
  • [32] Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
    Dakota Gustafson
    Jason E. Fish
    Jeffrey H. Lipton
    Nazanin Aghel
    Current Hematologic Malignancy Reports, 2020, 15 : 20 - 30
  • [33] Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study
    Murbach, Bruna
    Duarte, Gislaine
    Palma, Leonardo Carvalho
    Miranda, Eliana
    Duffles, Guilherme
    Furlin, Graziele Pavan
    Toni, Isabella
    De Souza, Carmino
    Binelli, Larissa
    Bassan, Vitor Leonardo
    de Castro, Fabiola Attie
    Figueiredo-Pontes, Lorena Lobo de
    Pagnano, Katia Borgia Barbosa
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan
    Wang, Ling-Yi
    Chu, Sung-Chao
    Lo, Yin
    Yang, Yen-Yun
    Chan, K. Arnold
    JAMA NETWORK OPEN, 2021, 4 (04) : E214132
  • [35] Predictive Value of BCR::ABL1 Transcripts Kinetics in the Molecular Relapse of Chronic Myeloid Leukemia Patients after Tyrosine Kinase Inhibitors Discontinuation: Results from the DES-CML Study
    Murbach, Bruna A.
    Oliveira, Gislaine Borba
    Palma, Leonardo Carvalho
    Miranda, Eliana C. M. C. M.
    Amarante, Guilherme D.
    Furlin, Graziele C. P.
    Toni, Isabella Macedo
    De Souza, Carmino
    Figueiredo-Pontes, Lorena
    Pagnano, Katia B.
    BLOOD, 2023, 142
  • [36] LONG TERM RESULTS WITH TYROSINE KINASE INHIBITORS BCR-ABL IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE
    Nunnz Yizel, Paz
    Gabriela, Silva Carreras F.
    Victoria, Vaitsekhovich
    Cecile, Mba
    Navascues Javier, Cornago
    Juan Luis, Steegmann Olmedillas
    HAEMATOLOGICA, 2016, 101 : 176 - 176
  • [37] PATTERNS OF CHANGE OF THE INHIBITORS OF THE TYROSINE KINASE BCR-ABL1 IN PATIENTS WITH CML IN CHRONIC PHASE IN THE ROUTINE CLINICAL PRACTICE SIMPLICITY STUDY
    Perez Encinas, M.
    Goldberg, S. L.
    Michallet, M.
    Hehlmann, R.
    Zyczynski, T.
    Foreman, A.
    Calimlim, B.
    Paquette, R.
    Simonsson, B.
    Gambacorti Passerini, C.
    Cortes, J.
    Zagorska, A.
    Rong, Y.
    Mauro, M.
    HAEMATOLOGICA, 2017, 102 : 285 - 285
  • [38] Does presence of complex translocations involving BCR::ABL1 in chronic myeloid leukemia affect the response rate to tyrosine kinase inhibitors? A systematic review of the literature
    Sharma, Diwakar
    Wilson, Christine
    Kumar, Sachin
    Ghose, Sampa
    Sahoo, Ranjit
    Sharawat, Surender K.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 71
  • [39] Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
    Anna Virgili
    Elisabeth P Nacheva
    Molecular Cytogenetics, 3
  • [40] Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
    Virgili, Anna
    Nacheva, Elisabeth P.
    MOLECULAR CYTOGENETICS, 2010, 3
12345